Debolosan, Lida D.

HRN: 24-09-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
CEFUROXIME 1.5GM (VIAL)
11/11/2023
11/17/2023
IV
1.5gm LD Then 750mg
Q8
Uti
Rejected 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines